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Abstract
This article is part of a series written for people responsible for making decisions about health policies and
programmes and for those who support these decision makers.
In this article, we discuss the following three questions: What is evidence? What is the role of
research evidence in informing health policy decisions? What is evidence-informed policymaking?
Evidence-informed health policymaking is an approach to policy decisions that aims to ensure that
decision making is well-informed by the best available research evidence. It is characterised by the
systematic and transparent access to, and appraisal of, evidence as an input into the policymaking
process. The overall process of policymaking is not assumed to be systematic and transparent.
However, within the overall process of policymaking, systematic processes are used to ensure that
relevant research is identified, appraised and used appropriately. These processes are transparent
in order to ensure that others can examine what research evidence was used to inform policy
decisions, as well as the judgements made about the evidence and its implications. Evidence-
informed policymaking helps policymakers gain an understanding of these processes.
About STP
This article is part of a series written for people responsible for
making decisions about health policies and programmes and for
those who support these decision makers. The series is intended
to help such people ensure that their decisions are well-informed
by the best available research evidence. The SUPPORT tools
and the ways in which they can be used are described in more
detail in the Introduction to this series [1]. A glossary for the
entire series is attached to each article (see Additional File 1).
Links to Spanish, Portuguese, French and Chinese translations
of this series can be found on the SUPPORT website (http://
www.support-collaboration.org). Feedback about how to
improve the tools in this series is welcome and should be sent to:
STP@nokc.no.
Scenario
You work in the Ministry of Health and the Minister of Health
has asked you to present options for improving the extent to
Published: 16 December 2009
Health Research Policy and Systems 2009, 7(Suppl 1):S1 doi:10.1186/1478-
4505-7-S1-S1
<supplement> <title> <p>SUPPORT Tools for evidence-informed health Policymaking (STP)</p> </title> <editor>Andy Oxman and Stephan Hanney</editor> <sponsor> <note>This series of articles was prepared as part of the SUPPORT project, which was supported by the European Commission’s  6th Framework INCO programme, contract 031939. The Norwegian Agency for Development Cooperation (Norad), the Alliance for Health Policy and Systems Research, and the Milbank Memorial Fund provided additional funding. None of the funders had a role in drafting, revising or approving the  content of this series.</note> </sponsor> <note>Guides</note> <url>http://www.biomedcentral.com/content/pdf/1478-4505-7-S1-info.pdf</url> </supplement>
This article is available from: http://www.health-policy-systems.com/content/7/S1/S1
© 2009 Oxman et al; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Health Research Policy and Systems 2009, 7(Suppl 1):S1 http://www.health-policy-systems.com/content/7/S1/S1
Page 2 of 7
(page number not for citation purposes)
which children are covered by health insurance. You want to
ensure that decisions about how to address this important prob-
lem are well-informed. You decide to commission a unit that
supports the Ministry of Health in using evidence in policymak-
ing to prepare a policy brief summarising both the best available
evidence characterising the problem and the options for
addressing it.
Background
For senior policymakers and others involved in scenarios
such as the one outlined above, this article provides a
basis for a common understanding of what constitutes
‘evidence’, the role of evidence in health policymaking,
what constitutes ‘evidence-informed health policymak-
ing’, and why it is important.
The achievement of universal and equitable access to
healthcare, of health-related Millennium Development
Goals (MDGs), and of other health goals is more likely to
be realised through well-informed health policies and
actions [2-5]. Unfortunately, the reality is that health pol-
icies are often not well-informed by research evidence [5-
8]. Poorly-informed decision making is one of the reasons
why services sometimes fail to reach those most in need,
why health indicators may be off-track and why many
countries are unlikely to be able to meet the health MDGs
[9]. Poorly-informed decision making may also contrib-
ute to problems related to the effectiveness, efficiency (i.e.
value for money), and equity of health systems.
Sub-Saharan Africa spends, on average, approximately
€80 per person on healthcare. In comparison, Asia spends
€190 and OECD high-income countries spend €2,700
per person [10]. With limited resources and a substantial
healthcare burden, it is vital that low- and middle-income
countries spend their healthcare budgets wisely. High-
income countries also face resource constraints due to
growing healthcare demands and costs.
Access to health services is often not equitable and this
may be exacerbated by inefficient health systems [11].
Once individuals do gain access, care may be substandard
or expensive. Effective and cheap interventions, such as
magnesium sulphate for eclampsia and pre-eclampsia, are
sometimes not used, or are simply unavailable [12]. Inef-
fective or unnecessarily expensive interventions (such as
routine episiotomies, and the provision of intravenous
fluids rather than oral rehydration solutions for diarrhoea
in children) are sometimes still used. Better use of
research evidence for selecting and promoting interven-
tions, and for deciding on the delivery, financial and gov-
ernance arrangements to support the use of these
interventions can help to reduce these problems, as illus-
trated by the examples shown in Table 1 and Additional
File 2.
An evidence-informed approach better enables policy-
makers to manage their own use of research evidence. It
also enables them to manage better the misuse of research
evidence by lobbyists, including researchers when they act
as advocates for particular policy positions. Evidence-
informed approaches allow policymakers to:
￿ Ask critical questions about the research evidence
available to support advocated policies
￿ Demonstrate that they are using good information
on which to base their decisions, and
￿ Ensure that evaluations of their initiatives are appro-
priate and that the outcomes being measured are real-
istic and agreed in advance 
An evidence-informed approach to policymaking also
allows policymakers to acknowledge that policies may be
informed by imperfect information. This recognition
reduces political risk because it sets in motion ways to
alter course if policies do not work as expected. There is a
far greater political risk when policies are advocated with-
out acknowledging the limitations of the available evi-
dence and when policies are then adhered to regardless of
the results. This renders policymakers subject to criticism
for failures related and unrelated to the policy itself.
Table 1: Examples of the use of research evidence in policymaking
Magnesium sulphate for the treatment of eclampsia and pre-eclampsia – an example of inadequate health system arrangements 
to support an inexpensive and effective intervention
There is high-quality evidence showing that magnesium sulphate, a low-cost drug, is effective for the treatment of eclampsia and pre-eclampsia 
[31,32]. However, the drug, like many other effective treatments in low- and middle-income countries, is still not yet widely available [12,33]. 
Failures in the registration, procurement, and distribution mechanisms for magnesium sulphate have contributed to its poor availability in countries 
such as Mozambique and Zimbabwe [12]. In other countries, problems include a lack of guidelines mandating the use of magnesium sulphate, the 
failure to include it on lists of essential drugs, a failure to implement existing guidelines, and restrictions on which facilities and health workers are 
authorised to administer it [33]. Although eclampsia and severe pre-eclampsia affect few women relative to the number of people affected by other 
healthcare problems, approximately 63,000 women worldwide die from these conditions every year. These conditions are also associated with 
neonatal deaths.
See Additional File 2 for further examples.Health Research Policy and Systems 2009, 7(Suppl 1):S1 http://www.health-policy-systems.com/content/7/S1/S1
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In this series of articles, our aim is to improve the effec-
tiveness, efficiency and equity of health policies through
the better use of research evidence to inform decisions.
Our focus is on decisions about how best to organise
health systems, including arrangements for delivering,
financing and governing health services, and strategies for
bringing about change [2,13]. In this series, we use these
types of decisions as examples to illustrate the ways in
which decision making can be better informed by research
evidence. Similar approaches can be used to inform deci-
sions about which programmes, services or drugs are pro-
vided [14].
What is evidence?
Discussions of evidence-based practice and evidence-
informed policymaking can generate debate about what
exactly constitutes ‘evidence’. A common understanding is
that “evidence concerns facts (actual or asserted) intended
for use in support of a conclusion” [15]. A fact, in turn, is
something known through experience or observation. An
important implication of this understanding is that evi-
dence can be used to support a conclusion, but it is not the
same as a conclusion. Evidence alone does not make deci-
sions.
This understanding of what evidence is has a number of
implications. Firstly, expert opinion is more than just evi-
dence. It is the combination of facts, the interpretation of
those facts, and conclusions. Evidence always informs
expert opinions. And appropriate use of that evidence
requires the identification of those facts (experience or
observations) that form the basis of the opinions, as well
as an appraisal of the extent to which the facts support the
conclusions [16].
Secondly, not all evidence is equally convincing. How
convincing evidence is depends on what sorts of observa-
tions were made and how well they were made. Research
evidence is generally more convincing than haphazard
observations because it uses systematic methods to collect
and analyse observations. Similarly, well designed and
executed research is more convincing than poorly
designed and executed research.
Thirdly, judgements about how much confidence can be
placed in different types of evidence (in other words, the
‘quality’ of the evidence) are made either implicitly or
explicitly. It is better to make these judgements systemati-
cally and explicitly in order to prevent errors, resolve dis-
agreements, facilitate critical appraisal, and communicate
information. This, in turn, requires explicit decisions
about the actual types of evidence that need to be consid-
ered.
Fourthly, all evidence is context-sensitive, given that all
observations are necessarily context-specific. Judgements
therefore always need to be made about the applicability
of evidence beyond its original context or setting. It is best
to make judgements about the applicability of this evi-
dence systematically and explicitly, for the same reasons
that it is best to make judgements about the quality of the
evidence in a systematic and explicit way.
Fifthly, ‘global evidence’ – i.e. the best evidence available
from around the world – is the best starting point for
judgements about the impacts of policies and pro-
grammes. Although all evidence is context-sensitive, deci-
sions based on a subset of observations that are presumed
to be more directly relevant to a specific context (such as
those undertaken in a particular country or population
group), can be misleading [17]. Judgements about
whether to base a conclusion on a subset of observations
are better informed if made in the context of all relevant
evidence [18].
Finally, it is necessary that local evidence (from the spe-
cific setting in which decisions and actions will be taken)
informs most other judgements about problems, options
for addressing problems, and implementation strategies.
This includes evidence of the presence of modifying fac-
tors in specific settings, the degree of need (e.g. the preva-
lence of disease or risk factors or problems with delivery,
financial or governance arrangements), values, costs and
the availability of resources.
What is the role of research evidence in 
informing health policy decisions?
To make well-informed decisions about issues such as
how best to provide universal and equitable access to
healthcare, policymakers need access to robust evidence.
Evidence is needed to clarify what services and pro-
grammes to offer or cover, how to deliver those services,
financial arrangements, governance arrangements, and
how to implement change [2]. Systematic reviews can be
used to inform decisions for key questions within each of
these domains [4-6]. An explanation of systematic reviews
is provided in Table 2 and examples of systematic reviews
are provided in Additional File 3. Figure 1 illustrates the
role of evidence from systematic reviews together with
local evidence in informing the judgements that need to
be made about health policy decisions.
Policy decisions are always influenced by factors other
than evidence. These include institutional constraints,
interests, ideas (including values), and external factors
like recessions. Research evidence is also not the only type
of information needed to inform the judgements neces-
sary for policy decision making. Nonetheless, strengthen-
ing the use of research evidence, and the ability ofHealth Research Policy and Systems 2009, 7(Suppl 1):S1 http://www.health-policy-systems.com/content/7/S1/S1
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policymakers to make appropriate judgements about its
relevance and quality, is a critical challenge that holds the
promise of helping to achieve significant health gains and
better use of resources.
What is evidence-informed policymaking?
For health policy decision making to be well-informed
rather than poorly informed, it is essential that more sys-
tematic and transparent processes are applied when
accessing and appraising research evidence. Evidence-
informed health policymaking is an approach to policy
decisions that is intended to ensure that decision making
is well-informed by the best available research evidence.
How this is done may vary, and will depend on the type
of decisions being made and their context. Nonetheless,
evidence-informed policymaking is characterised by the
fact that its access and appraisal of evidence as an input
into the policymaking process is both systematic and
transparent. This does not imply that the overall process
of policymaking will be systematic and transparent. How-
ever, within the overall process of policymaking, system-
atic processes are used to ensure that relevant research is
identified, appraised and used appropriately. These proc-
esses are transparent so that others can examine what
research evidence has been used to inform policy deci-
sions as well as the judgements made regarding the evi-
dence and its implications.
In this series, we describe ways in which evidence-
informed health policymaking can address common pol-
icymaking problems through more systematic and trans-
parent processes to facilitate well-informed decisions,
clarify evidence needs, find and assess evidence, and go
from evidence to decisions (as illustrated in Figure 2). The
advantages of systematic and transparent processes, such
as the ones that we describe in this series – compared to
processes that are non-systematic and not transparent –
are that they can help to protect against errors and bias.
This is illustrated by systematic reviews, examples of
which are shown in Table 2, which reduce the risk of
being misled by chance or by the biased selection and
appraisal of evidence.
Different types of evidence are relevant to different ques-
tions, and legitimate differences of opinion may exist as to
what constitutes the “best available evidence” for particu-
lar questions [19]. However, evidence-informed health
policymaking aims to ensure that relevant evidence is
identified and that judgements about issues such as what
evidence is relevant, the reliability and the applicability of
identified evidence are made systematically and transpar-
How evidence-informed health policymaking addresses com- mon policymaking problems Figure 2
How evidence-informed health policymaking addresses com-
mon policymaking problems
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Table 2: An explanation of systematic reviews
Systematic reviews are summaries of research evidence that address a clearly formulated question using systematic and explicit methods to identify, 
select, and critically appraise relevant research, and to collect and analyse data from the studies that are included in the review. Statistical methods 
(meta-analysis) may or may not be used to analyse and summarise the results of the included studies. Structured summaries of systematic reviews 
of health system arrangements can be found on the SUPPORT web pages (http://www.support-collaboration.org), including the examples 
summarised in Additional File 3.
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ently. Evidence-informed health policymaking also aims
to ensure that conflicts of interest do not influence such
judgements or any new research that is undertaken in sup-
port of policymaking.
Another essential characteristic of evidence-informed pol-
icymaking is that policymakers understand the systematic
processes used to ensure that relevant research is identi-
fied, appraised and used appropriately, as well as the
potential uses of such processes. This series of articles is
aimed at helping policymakers attain such an understand-
ing.
Since the beginning of the 1990s, there has been a drive
towards evidence-based medicine (EBM), which focused
initially on decision making by physicians [20,21]. This
drive has been extended to other health professionals and
consumers, and referred to as ‘evidence-based healthcare’
or ‘evidence-based practice’ as a way of reflecting its
broader scope. In the context of management and policy-
making, to which this approach has also been extended, it
is referred to as “evidence-based policy” [22]. In all of
these arenas, debate has focused on what exactly is meant
by an evidence-based approach, and how this approach
differs from usual practices, as well as the relative benefits
and risks. Both EBM and evidence-based policymaking
have been criticised for assuming that practice or policy
decisions are largely determined by research evidence
[4,23-25]. This criticism is largely a misperception of what
has been advocated. Neither decisions about individual
patients nor policy decisions are determined by evidence
alone. Judgements, values, and other factors, always play
a role.
Although the terms ‘evidence-based’ and ‘evidence-
informed’ can be used interchangeably, we have elected to
use the term ‘evidence-informed’ because it better
describes the role of evidence in policymaking and the
aspiration of improving the extent to which decisions are
well-informed by research evidence [4,26].
What evidence-informed policymaking is not
Like any other tool, those that are used to support the use
of evidence to inform policymaking can be misused.
Undesirable impacts arising from the inappropriate use of
evidence can include inefficient bureaucratic processes,
the inappropriate inhibition or delay of promising pro-
grammes, the misleading framing of problems, the
manipulation of public opinion, and the distortion of the
research agenda.Ways in which evidence can be misused
include using evidence selectively, stifling the appropriate
use of evidence, and creating of a spurious impression of
uncertainty. The best way to detect and prevent the inap-
propriate use of evidence is to use processes that are sys-
tematic and transparent, as we will describe in subsequent
articles in this series.
Conclusion
There is growing interest globally in making better use of
research evidence in decisions related to health. In 2004,
for example, the World Health Organization issued the
World Report on Knowledge for Better Health, which
included a chapter devoted to linking research to action
[27]. The Ministerial Summit on Health Research held
that same year in Mexico City, issued a statement on the
importance of research for better health and for strength-
ening health systems [28]. Further, in May 2005, the 58th
World Health Assembly passed a resolution acknowledg-
ing the Mexico Statement on Health Research, urging
member states “to establish or strengthen mechanisms to
transfer knowledge in support of evidence-based public
health and health-care delivery systems, and evidence-
based health-related policies” [29]. The need to continue
building on the progress made since the Mexico Ministe-
rial Summit was reflected too in the 2008 Bamako State-
ment issued by the Ministers of Health, Ministers of
Science and Technology, Ministers of Education, and
other Ministerial representatives of 53 countries [30]. A
first key step towards achieving this objective is to ensure
that policymakers and researchers have a shared under-
standing of what research evidence is and of the role of
research evidence in helping to inform policy decisions.
Resources
Useful documents and further reading
- Evidence-informed health policy video documenta-
ries: http://www.kunnskapssenteret.no/Artikler/
2061.cms – These compelling video documentaries
are part of a report on more than 150 organisations,
particularly in LMICs, that are building bridges
between evidence and policy (http://www.kunnskaps
senteret.no/Publikasjoner/469.cms). The video docu-
mentaries tell the stories of eight case studies across six
continents, where people are trying to improve health
systems by using research evidence to inform decision
making
- The Mexico statement on health research, 2004 http:/
/www.who.int/rpc/summit/agenda/
Mexico_Statement-English.pdf
- World Health Assembly. Resolution on health
research, 2005 http://www.who.int/rpc/meetings/
58th_WHA_resolution.pdf
- The Bamako call to action on research for health,
2008 http://www.who.int/rpc/news/
BAMAKOCALLTOACTIONFinalNov24.pdfHealth Research Policy and Systems 2009, 7(Suppl 1):S1 http://www.health-policy-systems.com/content/7/S1/S1
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- Chalmers I. If evidence-informed policy works in
practice, does it matter if it doesn’t work in theory?
Evidence & Policy 2005; 1:227-42 http://www.ingen
taconnect.com/content/tpp/ep/2005/00000001/
00000002/art00006
- Isaacs D, Fitzgerald D. Seven alternatives to evidence-
based medicine. BMJ 1999; 319:1618. http://
www.bmj.com/cgi/content/full/319/7225/1618
- Macintyre S, Petticrew M. Good intentions and
received wisdom are not enough. Journal of Epidemi-
ology and Community Health 2000; 54:802-3 http://
jech.bmj.com/cgi/content/full/54/11/802
- Moynihan R. Using health research in policy and
practice: Case studies from nine countries. Milbank
Memorial Fund report, 2004 http://www.mil
bank.org/reports/0409Moynihan/
0409Moynihan.html
Links to websites
- Evidence-Informed Policy Network (EVIPNet): http:/
/www.who.int/rpc/evipnet/en/, http://evip
net.bvsalud.org/php/index.php EVIPNet is an initia-
tive to promote the systematic use of health research
evidence in policymaking. Focusing on low- and mid-
dle-income countries, EVIPNet promotes partnerships
at the country level between policymakers, researchers
and civil society in order to facilitate both policy devel-
opment and policy implementation through the use
of the best scientific evidence available.
- Alliance for Health Policy and Systems Research:
http://www.who.int/alliance-hpsr/en/ The Alliance
HPSR is an international collaboration housed in the
World Health Organization (WHO). It aims to pro-
mote the generation and use of health policy and sys-
tems research as a means to improve the health
systems of developing countries.
- Canadian Health Services Research Foundation:
http://www.chsrf.ca/home_e.php This Foundation
promotes and funds management and policy research
in health services and nursing to increase the quality,
relevance and usefulness of this research for health
system policymakers and managers. In addition, the
foundation works with these health system decision
makers to support and enhance their use of research
evidence when addressing health management and
policy challenges.
- UK government’s Policy Hub: http://www.nationals
chool.gov.uk/policyhub/index.asp This site aims to
promote strategic thinking and improve policymaking
and delivery across government. It endeavours to pro-
vide users with access to a range of perspectives on pol-
icy matters.
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